Tracks heart transplant outcomes when donor hearts are moved in a special transport device
Studies heart transplant results when donor hearts travel in the SherpaPak device.
Key facts
- Who runs it
- Paragonix Technologies
- Where
- Manchester, United KingdomSee the siteAlso in 3 other countries, 21 sites
- Trial code
- Registry title
- Global Utilization And Registry Database for Improved heArt preservatioN
- Status
- Enrolling by invitation
- People taking part
- 4,000 people, planned
- Started
- 14 Feb 2020
- Expected to end
- 31 Dec 2029
- Type of study
- Observational, 3 groups
- Treatments tested
- SherpaPak Cardiac Transport System
- Record updated
- 16 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people on the waiting list for a first heart transplant, including children. The donor heart is carried in the SherpaPak Cardiac Transport System.
- Sex
- All sexes can join.
- Disease stage
- People registered as candidates for a first (primary) heart transplant.
- Earlier treatment
- People who have already had an organ transplant cannot join.
Main reasons for not taking part
- Donor heart does not meet the hospital's requirements for transplant
- Safe connection to the aorta cannot be made, for example the aortic root is not long enough
- People in prison
- People who have had a previous organ transplant
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Donor and donor hearts matched to the prospective recipient based upon institutional medical practice
- Registered male or female primary heart transplant candidates including pediatric candidates
Who cannot take part
- Donor and donor hearts that do not meet institutional clinical requirements for transplantation
- Patients who have had a previous organ transplant
- When safe connection with the aorta cannot be made, e.g., due to lack of enough length of the aortic root
- Patients who are incarcerated persons (prisoners)
Where in United Kingdom
Also in 3 other countries, 21 sites
- Manchester UniversityManchester, United KingdomEnrolling by invitation
About the trial
What the trial wants to find out
The primary objective of this study is to collect real-world clinical performance data to assess the clinical outcomes of patients receiving heart transplants using donor hearts transported via the SherpaPak CTS System. These results will be compared to outcomes of retrospective patients whose hearts were transported with the previous standard method.
Read full original descriptionShow less
CONCERT DCD is a substudy designed to assess the safety and feasibility of a direct procurement method for donation after circulatory death (DCD) heart procurement (CONCERT DCD) that utilizes preservation in a SherpaPak Cardiac Transport System. This DCD Substudy will be limited to approved GUARDIAN-Heart Registry sites who have been qualified to participate. The DCD Substudy will include prospective recipient identification and documentation of informed consent.
The 3 groups in the trial
- SherpaPak CTS Patients
Patients whose donor heart was transported with the SherpaPak CTS
Treatment: SherpaPak Cardiac Transport System
- Standard Transport Patients
Patients whose donor heart was transported with a method other than SherpaPak CTS in the past two years
- CONCERT DCD
Patients whose DCD heart was procured using a cold oxygenated flush with no reanimation and then transported in the SherpaPak CTS
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Global Utilization and Registry Database for Improved Heart Preservation
- Plain-language title
- Tracks heart transplant outcomes when donor hearts are moved in a special transport deviceGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Publications
- Early Outcomes in Patients With LVAD Undergoing Heart Transplant via Use of the SherpaPak Cardiac Transport System.Circulation. Heart failure, 2024
- Recipient Outcomes With Extended Criteria Donors Using Advanced Heart Preservation: An Analysis of the GUARDIAN-Heart Registry.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2024
- Record updated
- 16 October 2026